- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT07497633
Spontaneous Coronary Artery Dissection (SCAD) Avatar Study
March 23, 2026 updated by: Sharonne Hayes, Mayo Clinic
Spontaneous Coronary Artery Dissection (SCAD) Avatar Study (Pilot)
The purpose of this study is to evaluate patient satisfaction, comfort, and trust in interacting with an avatar compared with speaking to a human clinician during a pre clinical visit.
Study Overview
Status
Not yet recruiting
Conditions
Intervention / Treatment
Study Type
Observational
Enrollment (Estimated)
150
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Amanda Priebe
- Phone Number: 507-422-6932
- Email: Priebe.Amanda@mayo.edu
Study Locations
-
-
Minnesota
-
Rochester, Minnesota, United States, 55905
- Mayo Clinic
-
Principal Investigator:
- Sharonne N. Hayes, M.D.
-
Contact:
- Amanda Priebe
- Phone Number: 507-422-6932
- Email: Priebe.Amanda@mayo.edu
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
- Adult
- Older Adult
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
Eligible SCAD patients will be identified once they have a confirmed Mayo Clinic SCAD Clinic appointment
Description
Inclusion Criteria:
- All patients scheduled for a SCAD appointment at Mayo Clinic
Exclusion Criteria:
- Not Applicable
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
Cohorts and Interventions
Group / Cohort |
Intervention / Treatment |
|---|---|
|
Video Avatar
|
Patients will undergo a pre-visit interview with a Video Avatar (LLM powered digital interviewer presented with on-screen video)
|
|
Voice-Only Avatar
|
Patients will undergo a pre-visit interview with a Voice-Only Avatar ( LLM-powered interviewer delivered without visuals)
|
|
Human Interview
|
Patients will undergo a Human Interview conducted by trained Mayo personnel
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Patient Satisfaction
Time Frame: Baseline
|
Patient satisfaction with the AI avatar (Visual/Voice and Voice only) will be assessed using a structured questionnaire completed after the AI-conducted pre-interview.
Responses will be measured on a numeric Likert scale, with higher scores indicating greater satisfaction and comfort with the AI avatar interaction.
|
Baseline
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Sharonne Hayes, M.D, Mayo Clinic
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Estimated)
May 1, 2026
Primary Completion (Estimated)
May 1, 2028
Study Completion (Estimated)
May 1, 2028
Study Registration Dates
First Submitted
March 23, 2026
First Submitted That Met QC Criteria
March 23, 2026
First Posted (Actual)
March 27, 2026
Study Record Updates
Last Update Posted (Actual)
March 27, 2026
Last Update Submitted That Met QC Criteria
March 23, 2026
Last Verified
March 1, 2026
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- 25-014040
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Spontaneous Coronary Artery Dissection
-
Mayo ClinicNational Heart, Lung, and Blood Institute (NHLBI)RecruitingSpontaneous Coronary Artery DissectionUnited States
-
Mayo ClinicRecruitingSpontaneous Coronary Artery Dissection | Fibromuscular DysplasiaUnited States
-
Vanderbilt University Medical CenterFibromuscular Dysplasia Society of AmericaRecruitingSpontaneous Coronary Artery Dissection | Fibromuscular Dysplasia | Fibromuscular Dysplasia of ArteriesUnited States
-
University of LeicesterUniversity Hospitals, Leicester; Edinburgh Napier UniversityRecruitingSpontaneous Coronary Artery DissectionUnited Kingdom
-
Icahn School of Medicine at Mount SinaiRecruitingSpontaneous Coronary Artery Dissection | Fibromuscular Dysplasia | Cervical Artery DissectionUnited States
-
Intermountain Health Care, Inc.Enrolling by invitationSpontaneous Coronary Artery Dissection
-
Hospital Israelita Albert EinsteinRecruitingCoronary Artery Dissection, SpontaneousBrazil
-
Mayo ClinicRecruitingSpontaneous Coronary Artery Dissection | SCADUnited States
-
Mayo ClinicRecruitingSpontaneous Coronary Artery Dissection | SCADUnited States
-
SCAD AlliancePERFUSE Study GroupActive, not recruitingSpontaneous Coronary Artery DissectionUnited States, Australia
Clinical Trials on Video Avatar Interview
-
Saint-Joseph UniversityRecruitingAnxiety | Local Anesthesia | Fear | Pediatric DentistryLebanon
-
Yonsei UniversitySeverance HospitalRecruitingRadiotherapy | Patient EducationSouth Korea
-
The Hospital for Sick ChildrenUniversity of Colorado, Denver; Mayo Clinic; Baylor College of Medicine; Children... and other collaboratorsCompleted
-
University of Missouri, Kansas CityCompletedCardiovascular DiseaseUnited States
-
Miami VA Healthcare SystemPfizerCompletedOveractive BladderUnited States
-
Ciusss de L'Est de l'Île de MontréalActive, not recruitingPsychotic Disorders | Mental Health Disorder | Cannabis Use DisorderCanada
-
Ciusss de L'Est de l'Île de MontréalCanadian Institutes of Health Research (CIHR)RecruitingPsychotic Disorders | Mental Health Disorder | Cannabis Use DisorderCanada
-
Ciusss de L'Est de l'Île de MontréalActive, not recruitingTreatment-Resistant Major Depressive DisorderCanada
-
Memorial Sloan Kettering Cancer CenterNational Institutes of Health (NIH); Muzzy Lane SoftwareCompleted
-
Johns Hopkins UniversityCompletedTobacco SmokingUnited States